RBM5 and acute myeloid leukemia: Currently, there are limited studies on the correlation between RBM5-AS1 and AML. One study demonstrated that RBM5-AS1 is highly expressed in the bone marrow of AML patients and may influence cell proliferation, migration, and invasion by modulating the Wnt/β-catenin pathway (Wang et al., 2023b).